نتائج البحث - "Deurloo, Regula"

1

دورية أكاديمية

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

مصطلحات موضوعية: biomarkers, breast cancer, HER2-positive, hormone receptor-positive, immune markers, info:eu-repo/classification/ddc/610, ddc:610

العلاقة: 4884

الإتاحة: https://ul.qucosa.de/id/qucosa%3A84985Test
https://ul.qucosa.de/api/qucosa%3A84985/attachment/ATT-0Test/

النص الكامل

2

دورية أكاديمية

Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

المؤلفون: de Vries, Elisabeth G.E., Rüschoff, Josef, Lolkema, Martijn, Tabernero, Josep, Gianni, Luca, Voest, Emile, de Groot, Derk Jan A., Castellano, Daniel, Erb, Gilles, Naab, Julia, Donica, Margarita, Deurloo, Regula, van der Heijden, Michiel S., Viale, Giuseppe

المصدر: de Vries , E G E , Rüschoff , J , Lolkema , M , Tabernero , J , Gianni , L , Voest , E , de Groot , D J A , Castellano , D , Erb , G , Naab , J , Donica , M , Deurloo , R , van der Heijden , M S & Viale , G 2023 , ' Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma ' , Cancer Medicine , vol. 12 , no. 11 , pp. 12071-12083 . ....

مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

وصف الملف: application/pdf

العلاقة: https://pure.eur.nl/en/publications/f3cf369e-b247-442c-a190-80039fdee21bTest

الإتاحة: https://doi.org/10.1002/cam4.5893Test
https://pure.eur.nl/en/publications/f3cf369e-b247-442c-a190-80039fdee21bTest
https://pure.eur.nl/ws/files/94605961/Phase_II_study_KAMELEON_of_single_agent_T_DM1_in_patients_with_HER2_positive_advanced_urothelial_bladder_cancer_or_pancreatic_cancer_cholangiocarcinoma.pdfTest
http://www.scopus.com/inward/record.url?scp=85158064865&partnerID=8YFLogxKTest

View record in BASE

3

دورية أكاديمية

Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130

المؤلفون: Badve, Sunil S, Penault-Llorca, Frédérique, Reis-Filho, Jorge S, Deurloo, Regula, Siziopikou, Kalliopi P, D'Arrigo, Corrado, Viale, Giuseppe

المساهمون: S.S. Badve, F. Penault-Llorca, J.S. Reis-Filho, R. Deurloo, K.P. Siziopikou, C. D'Arrigo, G. Viale

مصطلحات موضوعية: B7-H1 Antigen, Human, Immunohistochemistry, Prognosi, Tumor Microenvironment, Triple Negative Breast Neoplasms, Settore MED/08 - Anatomia Patologica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34286340; info:eu-repo/semantics/altIdentifier/wos/WOS:000792260900001; volume:114; issue:5; firstpage:664; lastpage:675; numberofpages:12; journal:JOURNAL OF THE NATIONAL CANCER INSTITUTE; https://hdl.handle.net/2434/936167Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118532384

الإتاحة: https://doi.org/10.1093/jnci/djab121Test
https://hdl.handle.net/2434/936167Test

View record in BASE

4

دورية أكاديمية

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

المساهمون: 임석아, Im, Seock-Ah

مصطلحات موضوعية: COLON-CANCER, NEOADJUVANT CHEMOTHERAPY, PLUS DOCETAXEL, III TRIAL, METAANALYSIS

العلاقة: The Lancet Oncology, Vol.14 No.10, pp.933-942; 130000; https://hdl.handle.net/10371/177234Test; 000323942500039; 2-s2.0-84883050174

الإتاحة: https://doi.org/10.1016/S1470-2045Test(13)70335-8
https://hdl.handle.net/10371/177234Test

View record in BASE

5

دورية أكاديمية

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

المؤلفون: Garcia, Josep, Hurwitz, Herbert I., Sandler, Alan B., Miles, David, Coleman, Robert L, Deurloo, Regula, Chinot, Olivier L

المساهمون: F. Hoffmann-La Roche Ltd

المصدر: Cancer Treatment Reviews ; volume 86, page 102017 ; ISSN 0305-7372

الإتاحة: https://doi.org/10.1016/j.ctrv.2020.102017Test
https://api.elsevier.com/content/article/PII:S0305737220300554?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0305737220300554?httpAccept=text/plainTest

View record in BASE

6

دورية أكاديمية

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

المصدر: Journal of Clinical Oncology; 8/1/2023, Vol. 41 Issue 22, p3796-3804, 9p

7

دورية أكاديمية

Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma.

المؤلفون: de Vries, Elisabeth G. E., Rüschoff, Josef, Lolkema, Martijn, Tabernero, Josep, Gianni, Luca, Voest, Emile, de Groot, Derk Jan A., Castellano, Daniel, Erb, Gilles, Naab, Julia, Donica, Margarita, Deurloo, Regula, van der Heijden, Michiel S., Viale, Giuseppe

المصدر: Cancer Medicine; Jun2023, Vol. 12 Issue 11, p12071-12083, 13p

مصطلحات موضوعية: BLADDER cancer, TRANSITIONAL cell carcinoma, PANCREATIC cancer, EPIDERMAL growth factor receptors, CHOLANGIOCARCINOMA

النص الكامل

8

دورية أكاديمية

Determining PD-L1 Status in Patients with Triple-Negative Breast Cancer: Lessons Learned from IMpassion130

المؤلفون: Badve, Sunil, Penault-Llorca, Frédérique, Reis-Filho, Jorge, Deurloo, Regula, Siziopikou, Kalliopi, D’arrigo, Corrado, Viale, Giuseppe

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER

المصدر: ISSN: 0027-8874 ; EISSN: 1460-2105.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

العلاقة: hal-03295393; https://hal.science/hal-03295393Test

الإتاحة: https://doi.org/10.1093/jnci/djab121Test
https://hal.science/hal-03295393Test

View record in BASE